Covered recipient · General Payments record
LAURA POPKO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2024
$183.54
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $183.54 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $55.95 | 2 |
| Merck Sharp & Dohme Corporation | $36.86 | 2 |
| Lilly USA, LLC | $30.31 | 1 |
| GlaxoSmithKline, LLC. | $28.89 | 2 |
| ABBVIE INC. | $16.88 | 1 |
| Novo Nordisk AS | $14.65 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $183.54 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.88 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105293836 | CMS |
| Amgen Inc. | $28.91 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111678718 | CMS |
| Amgen Inc. | $27.04 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111678720 | CMS |
| GlaxoSmithKline, LLC. | $14.57 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116281256 | CMS |
| GlaxoSmithKline, LLC. | $14.32 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116203761 | CMS |
| Lilly USA, LLC | $30.31 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135143993 | CMS |
| Merck Sharp & Dohme LLC | $15.81 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141774742 | CMS |
| Merck Sharp & Dohme LLC | $21.05 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141939761 | CMS |
| Novo Nordisk Inc | $14.65 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097709130 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.